Agree the share price is cheap but there is more than one
Agree the share price is cheap but there is more than one way to stop the bleeding. It can be a call to arms: “to the barricade!” with purchase orders but I’ll mention in passing over 4 million shares were borrowed short an hour before close, returned around the close. You can do a lot of damage with that volume of shares. Without news that turns the tide it’s easy to push the price down. Dedicated longs have tried to absorb the onslaught for a long time. I’ve lowered my average significantly but under strict orders from the better half to cease and desist. On the bright side there is a flip side we should remind ourselves of…I have mentioned before my sense is that extant shares are moving inexorably to people with faith and commitment….Walsh knows something about that. I’m sure the flippers are out there but many are holding on to their poker chips. When they light up the Saturn rocket I suspect they are not going to let go of those shares for cheap. Sold too soon is a lesson few learn, right up there with lacking the patience for a situation to develop. Borrowed shares must be bought back and when people see a rocket going to Tomorrowland they will want a seat and will have to pay for the privilege…tides move in two directions.
The OTHER way to help reverse the tide is for the Company to show up with something palpable. I think it will come in due course so I will wait for the game changing event, but NOW would be a good time to deliver on the change in communication strategy they talked about. Put some color on things; as mightycydy pointed out…why are we needing to do a preclinical study for NASH? Explain it…there must be a reason…one was already done and the mice liked how they felt in the treatment group…and we have something more valuable in a human study. Those mice sipping high fructose, high fat cocktails are not the same as positive data from a human trial. If we are going back to the mice for comment, explain it.
Right up there with truly market moving news quality communications would help…I hate being reduced to guessing, conjecture and reading entrails to divine what is going on.
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...
Continue Reading
An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...
Continue Reading
ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...
Continue Reading
Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...
Continue Reading
Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...
Continue Reading
Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...
Continue Reading
Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...
Continue Reading
Forget the stereotypes that tag University of Phoenix as just another factory for diplomas. The latest survey results paint a picture of graduates who seem to be real go-getters in the workplace. We’ve got managers from all over singing the praises of these alums, with a whopping 96% ready to vouch for them stepping into bigger roles. Not just talk, folks, this is their...
Continue Reading
Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...
Continue Reading
Big Moves in the Legal Arena Holy guacamole, folks—Kevin Burke just landed a plum spot at Latham & Watkins, stepping into their Mergers & Acquisitions and Private Equity team in New York. You might ask, who cares? Well, savvy investors and PE players should pay attention because moving legal minds like Burke can stir up the whole private equity scene. Who's This Burke...
Continue Reading
Top 5 Most Recently Viewed Articles
Allegion Expands Offerings with Performance Series Locks Allegion, a renowned name in security solutions, has just unveiled the Schlage Performance Series Locks, a new suite designed specifically for commercial spaces. These locks provide the perfect blend of style, security, and functionality, catering to the diverse needs of modern businesses. Innovative Solutions for...
Continue Reading
AM Best Confirms Credit Ratings for Transmonde Services Insurance Company AM Best has recently affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a" (Excellent) for Transmonde Services Insurance Company Limited. This affirmation highlights the company's solid financial standing and acknowledges its stable outlook in the...
Continue Reading
How Marathon Petroleum Has Surged in Value Over the past decade, Marathon Petroleum (MPC) has shown impressive performance, outperforming the market by an annualized rate of 1.07%, yielding an average annual return of 14.15%. Currently, the company's market capitalization stands at an impressive $49.97 billion, reflecting its strong position in the marketplace. The Impact...
Continue Reading
Women’s Experiences with Birth Control and Side Effects Recent findings shed light on the experiences of women using various birth control methods. A survey conducted involving over 450 women aged 18 to 70 highlighted some compelling results regarding the use of contraceptives. While a majority reported satisfaction with their current methods, a notable portion, nearly...
Continue Reading
Wealthcare Secures A New Financial Partnership Wealthcare Capital Management, a pioneering technology-enabled Registered Investment Advisor (RIA), has made remarkable strides in the first half of 2025. The firm has established a partnership with Sammons Financial Group, reinforcing its commitment to enhance the support provided to independent financial advisors. This...
Continue Reading